Introduction There is strong evidence that biopsychosocial approaches are efficacious in the management of chronic pain. However, implementation of these approaches in clinical practice is known not to account for the beliefs and values of culturally and linguistically diverse (CALD) patients. This limitation in translation of research contributes to the disparities in outcomes for CALD patients with chronic pain adding to the socioeconomic burden of this prevalent condition. Cultural adaptation of chronic pain assessment and management is urgently required. Thus, the aim of this pilot randomised controlled trial (RCT) is to determine the feasibility, participant acceptance with and clinical effectiveness of a culturally adapted physiotherapy assessment and treatment approach when contrasted with ‘usual evidence based physiotherapy care’ for three CALD communities.
Methods and analysis Using a participant-blinded and assessor-blinded randomised controlled pilot design, patients with chronic pain who self-identify as Assyrian, Mandaean or Vietnamese will be randomised to either 'culturally adapted physiotherapy assessment and treatment' or ‘evidence informed usual physiotherapy care'. We will recruit 16 participants from each ethnocultural community that will give a total of 24 participants in each treatment arm. Both groups will receive physiotherapy treatment for up to 10 sessions over 3 months. Outcomes including feasibility data, acceptance with the culturally adapted intervention, functional and pain-related measures will be collected at baseline and 3 months by a blinded assessor. Analysis will be descriptive for feasibility outcomes, while measures for clinical effectiveness will be explored using independent samples t-tests and repeated measures analysis of variance. This analysis will inform sample size estimates while also allowing for identification of revisions in the protocol or intervention prior to a larger scale RCT.
Ethics and dissemination This trial has full ethical approval (HREC/16/LPOOL/194). The results from this pilot RCT will be presented at scientific meetings and published in peer-reviewed journals.
Trial registration number ACTRN12616000857404
Statistics from Altmetric.com
Strengths and limitations of this study
Randomised, assessor-blind and participant-blind controlled trial.
Our study is the first to provide information on the feasibility of a culturally adapted physiotherapy assessment and treatment protocol for culturally and linguistically diverse patients with chronic pain.
The results of this pilot trial will enable clinicians and service providers to make informed decisions regarding the feasibility of adapting physiotherapy approaches for culturally and linguistically diverse patients.
The results will provide data for a fully powered trial.
This is a feasibility study and as such is not adequately powered to determine treatment effectiveness.
Chronic pain is a significant global health problem.1 With an economic cost cited between $A34 billion and US$635 billion annually, chronic pain conditions carry the second highest burden of disease globally.1–3 The high economic cost has been attributed to the complex and heterogeneous nature of conditions that sit under the banner of chronic pain.4 While many conditions may have similar biological diagnoses, wide variability in symptom behaviour and response to treatments has been observed and reported.5–8 Understanding the factors responsible for the variability in chronic pain presentations is paramount if the personal, social and economic burden of chronic pain is to be ameliorated.9
The prevailing clinical approach to the assessment and treatment of chronic pain is based on the biopsychosocial model.10 While high-quality evidence supports the use of the biopsychosocial approach, most research into chronic pain has focused on understanding the biological and psychological dimensions of the model.9 11 Ethnocultural influences, as part of the social dimension, have been overlooked when evaluating research into interventions for chronic pain.12 As such, current pain management programmes fail to consider the relationship between ethnoculture and chronic pain and have limited applicability for contemporary multicultural societies.12
One important component of biopsychosocial management is physiotherapy.13 Our review of current chronic pain interventions, including physiotherapy, demonstrated limited effectiveness in culturally and linguistically diverse (CALD) populations.12 This may be due to variability in the explanatory frameworks held by culturally diverse communities that may not align with a biopsychosocial understanding of chronic pain.14–16 For example, in some communities, psychological influences are rejected in favour of biological explanations, while in others, spiritual, social and environmental factors are considered causative.14–15, 17–20 Thus, for pain management strategies to be relevant and clinically effective in culturally diverse communities, cultural adaptation of interventions is required.
Cultural adaptation of treatment refers to the process of making therapeutic goals, language, content and processes consistent with those of the target cohort.21 Evidence from psychotherapy research suggests that when programmes are culturally adapted, treatment relevance, credibility and efficacy is enhanced.22 Therefore, the aim of this pilot randomised controlled trial (RCT) is to determine the feasibility, acceptance (measured by attendance, adherence and satisfaction) and clinical effectiveness of a culturally adapted physiotherapy assessment and treatment approach when contrasted with ‘usual evidence based physiotherapy care’ for three unique CALD communities. Furthermore, this pilot RCT will be used to provide data to support a sample size calculation for a fully powered trial should trends of effectiveness be present.
Methods and analysis
A pilot assessor and participant blinded RCT design will be used. This trial has been designed according to the CONsolidated Standards of Reporting Trials (CONSORT) statement23 and will be reported according to the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement24 and the template for intervention description and replication (TIDieR) checklist25 (see online supplementary material). The trial was registered with the Australian and New Zealand Clinical Trials Registry (ACTRN12616000857404) on 30 June 2016.
Participants and recruitment
Adults (aged 18 years of age and over) with chronic non-specific musculoskeletal pain (confirmed by a clinical physiotherapy assessment) of greater than 3 months’ duration and who self-identify as a member of the Vietnamese, Assyrian or Mandaean ethnocultural community will be eligible. Prospective participants will need to consent to participate in physiotherapy treatment and be available to attend a pain management programme, if randomised to this treatment arm. Participants will be excluded if they have specific diagnoses necessitating other treatment (ie, complex regional pain syndrome, radiculopathy, wait listed for surgery or complex psychological disorders) that prevents their participation in the pain management programme. Prospective participants will be excluded if they have undergone surgery in the 3 months prior to assessment, as we cannot guarantee symptom stability. Furthermore, as participation will involve group exercise participation, participants requiring assistance for mobility or transfers (including the use of an aid other than a single point stick) will be excluded. Prospective participants will be recruited from the outpatient referral lists of two public hospital physiotherapy departments within South West Sydney Local Health District (SWSLHD) (Fairfield and Liverpool Hospitals) in Australia. The recruiting physiotherapists will screen participants for eligibility. Those meeting the inclusion criteria and consenting to participate will complete the baseline assessment and subsequent initial outcome assessment.
Information on study procedures is summarised in the CONSORT diagram (figure 1).
Sixteen consecutive participants from each community (Assyrian, Mandaean and Vietnamese) will be randomised to (1) ‘culturally adapted physiotherapy assessment and treatment’ or (2) ‘evidence informed usual physiotherapy care’. A computer-generated sequence with a 1:1 allocation ratio for each ethnocultural community will be prepared by an independent investigator not involved in the recruitment of participants or delivery of the interventions. Labelled pieces of paper with the intervention arm will be placed in sealed opaque envelopes according to the random sequence. The envelopes will be labelled with a participant number according to their entry sequence in the study. The envelopes will be managed by a central administrative officer and kept in a secure location. This officer will be contacted once a participant is consented and will be responsible for allocating to the treatment arm and arranging subsequent physiotherapy appointments, according to the treatment allocation.
Participants and the outcome assessor will be blinded to group allocation. Participants will be blinded to their treatment category and whether their physiotherapist has been trained in the culturally responsive protocol. The success of participant blinding will be assessed by a yes/no question: ‘do you think your physiotherapist has been trained in culturally responsive treatments for chronic pain?' As both treatment arms require active treatment, it is not possible to blind the physiotherapists to treatment allocation. An investigator, blinded to the treatment allocation, will collect outcome measures at 3 months. Assessor blinding will be verified with a yes/no question: ‘did you know which treatment arm the participant belonged to?'
(1) Culturally adapted physiotherapy assessment and treatment
This intervention will be delivered by a ‘senior’ musculoskeletal physiotherapist,26 with 11 years’ clinical experience, who developed the culturally adapted pain management physiotherapy protocol. The protocol was developed following extensive qualitative enquiry, clinical expertise and review of the literature. Participants randomised to this intervention arm will attend a combination of group therapy sessions (approximately 2 hours’ duration, once a week, for 6 weeks) and up to four individualised physiotherapy sessions of 30 min duration, until treatment conclusion at 3 months. Groups will be delivered in a start–stop format and limited to eight participants for each community; however, family/friends will be allowed to attend (table 1). The group sessions will be facilitated by a culturally sensitive bilingual health educator and conducted at a local community room/hall that is accessible by patients from CALD backgrounds. Bilingual health educators will undergo two formal training sessions with the treating physiotherapist, to familiarise them with the programme content. The individual physiotherapy sessions will be delivered by the same physiotherapist and with the assistance of an interpreter as required.
The programme content is based on current evidence-based guidelines for the management of chronic pain that aim to improve patients' physical and socio-occupational functioning using cognitive behavioural approaches.27–29 Cognitive behavioural approaches, adopted by physiotherapists, are theorised to work by targeting unhelpful pain beliefs and facilitating increased confidence in movement through education, impairment focused exercise and re-engagement with usual activities despite pain.30 The success of these approaches hinge on the patient’s acceptance of treatment concepts, active participation and a working therapeutic alliance between the patient and physiotherapist. These are all recognised as barriers when working with CALD patients.12 31 To address these barriers, our programme has adapted evidence-based pain management content to reflect the beliefs, values and behaviours of the three communities of interest, using findings from our qualitative research with each ethnocultural community (table 1). We hypothesise that successful adaptation will ensure the mechanism of action is the same and that evidence-based pain management approaches will be applicable to these CALD communities.
Two adaptation frameworks underpinned the process of cultural adaptation.21 32 Information gathering in the form of literature reviews, multicultural health worker consultation and focus groups was undertaken to inform the adaptation content (phase one). The findings of these focus groups are under-review elsewhere. Eight specific dimensions of physiotherapy and pain management interventions were then considered to ensure that deep and surface level adaptations were included.21 33 These included language, persons, metaphors, content, concepts, goals, methods and context21 dimensions that formed part of the manualised programme content for the three communities (phase two) (table 1). Phase three represents the current pilot phase, whereby the adapted programmes are piloted to evaluate whether the goals of the adaptation have been achieved and to identify difficulties with the programme and/or evaluation process.32 Specific examples of the adaptation elements are displayed in table 1. The programme content has been manualised and has been designed to be delivered by physiotherapists after completion of a maximum of 24 hours of further training. Training will focus on improving cultural knowledge, developing skills in cross-cultural communication, eliciting explanatory models of illness and implementing physiotherapy interventions in the context of cultural diversity.31 This dose (ie. 24 hours of training) is consistent with doses reported in cultural responsiveness education programmes in the literature.34
Individual physiotherapy sessions will be tailored to suit the needs of each patient, following a culturally informed assessment. Using a pictorial tool, the physiotherapist will explore aspects of cultural beliefs and values, migration history and circumstances, degree of alignment with ethnocultural community, spiritual domains and extract the patient's explanatory model of illness.34 The remainder of the assessment, including physical examination procedures and diagnostic explanations, will be framed according to the patient’s explanatory model of illness.35 Findings from our previous focus groups have highlighted that a biomedical framework is held by Assyrian communities, a biopsychosocial framework by Mandaean communities and a predominant Traditional Medicine Am–Duong framework by Vietnamese communities. The remainder of the individual sessions will be used following participation in the group programme, according to the specific needs of each individual. All participants will be given a home exercise programme, the dosage and timing of which will be determined following their culturally informed assessment.
(2) Evidence-informed usual care
Patients allocated to this treatment arm will receive treatment delivered by one of five physiotherapists who have not been trained in the culturally adapted assessment or treatment protocols. Importantly, all treating physiotherapists will be ‘senior’ level musculoskeletal physiotherapists26 or have more than 4 years’ clinical experience and the supervision/support of their senior and specialist musculoskeletal physiotherapy colleagues. All treating physiotherapists will attend a training session familiarising them with evidence-based guidelines for the management of chronic pain, including cognitive–behavioural therapy approaches, prior to commencing the trial. This session will incorporate concepts including explaining mechanisms of pain, goal setting, ergonomics, pacing, flare-up management, active coping strategies and exercise prescription for chronic pain.
The mode of delivery of the treatment (individual or group) is at the discretion of the therapist and what is usual practice for the specific community at each site. All participants will have access to professional health interpreting services to facilitate therapy sessions if required and will be delivered in a hospital outpatient setting. Physiotherapists will be able to use their clinical judgement to determine the specific dose and type of treatment for each patient according to their assessment. While a home exercise programme is consistent with best practice, the specifics of exercise prescription will be left to the treating physiotherapist. A maximum of 10 sessions of physiotherapy, of up to 1-hour duration (as needed), over the 3-month intervention period will be set to ensure comparability. This number is consistent with the average number of physiotherapy sessions commonly reported in clinical trials for the management of chronic pain disorders.27 36–41
All treating physiotherapists will be asked to complete a treatment diary to allow adherence to the ‘evidence based’ care or ‘culturally adapted pain management physiotherapy protocol’ to be established. Physiotherapist adherence to evidence-based treatment components will be reported as the percentage of core components used by the 'usual care' physiotherapist over the treatment period, calculated from therapist treatment diaries.
All personnel involved in data collection will be blinded. Study documents will be de-identified and stored in accordance with SWSLHD Human Research Ethics Committee (HREC) guidelines. Primary outcome measures include measures relevant to determine the feasibility of conducting a fully powered RCT and acceptance of the culturally adapted intervention arm. Given the complexities of research inclusive of CALD communities, challenges that may arise, as part of the clinical trial process, must be determined.
Feasibility data will be collected during the recruitment phase each time a new referral is assessed and will include the number of referrals screened, the number meeting the inclusion criteria and the number that agree to be randomised. The number of dropouts will be evaluated weekly until treatment conclusion and defined as the number of participants who withdraw or fail to continue with their allocated treatment. Finally, the number of participants that attend the final outcome assessment will be calculated at the 3-month assessment to ascertain the proportion of participants lost to follow-up.
Acceptance (attendance, adherence and satisfaction)
Attendance will be calculated as the proportion of the sessions attended relative to the number of sessions scheduled. Adherence to the intervention and its specific components will be calculated as the average number of home exercise sessions completed a week, relative to the number of sessions prescribed. The number of home exercise sessions per week will be calculated by review of participant logbooks and patient self-report. Both attendance and adherence will be assessed weekly from the start to treatment conclusion at 3 months. Patient satisfaction with treatment will be evaluated at the 3-month assessment using the Client Satisfaction Questionnaire (CSQ-8).42 The CSQ-8 is an eight-item instrument, available in Vietnamese and Arabic, with demonstrated reliability and excellent internal consistency for evaluating satisfaction with health services.42 43
Clinical effectiveness trends
Secondary outcome measures will include the clinical measures intended to be used in a full-scale RCT. Secondary outcome measures will be collected at baseline (pre-randomisation) and at 3-month outcome assessment.
The 6 min walk test is a reliable and valid tool that has been used to detect changes in functional performance following exercise-based interventions. It has been used in previous clinical trials and evaluated to be sensitive to change for patients with cardiac, respiratory and chronic conditions such as arthritis, fibromyalgia and chronic pain.44–48
The 1 min sit-to-stand test is a reliable and valid measure of lower body strength and endurance that has been previously used to evaluate functional performance in chronic pain, chronic obstructive pulmonary disease (COPD), renal transplant and healthy adult populations.49–54 The test represents a fundamental task performed more than 60 times/day in a healthy adult population.55
The Pictorial Representation of Illness and Self-Measure is a reliable pictorial tool to measure the burden of suffering due to an illness and has been validated for use with a range of chronic conditions including chronic pain, rheumatoid arthritis, systematic lupus erythematosus, post-traumatic stress disorder and COPD.56–59
The Brief Pain Inventory (Short Form) is a reliable and valid self-administered questionnaire that assesses four items of pain severity and seven items of pain interference on fundamental aspects of daily living.60 61 It has been widely used as an outcome measure in chronic pain trials and has been validated in Arabic and Vietnamese.60 62–66
The Depression, Anxiety and Stress Scale Short Version (DASS-21) is a 21-item self-reported questionnaire that evaluates the severity of core symptoms of depression, anxiety and stress.67 The psychometric properties of the DASS-21 have been established in a variety of chronic pain cohorts,68–70 and it has been validated for use with Arabic-speaking and Vietnamese-speaking patients.71 72
Sample size calculation
Based on previous recommendations for the sample sizes used in pilot studies and to allow for equal numbers of participants in both treatment arms, 24 participants will be recruited to each group.73 74 According to Hertzog,73 a sample of 20 participants per group may be sufficient to generate reasonable bias-corrected estimates for medium to large effects. Therefore, to allow for equal numbers of participants in both treatment arms and the potential for dropouts, 24 participants will be recruited to each group. This will equate to 48 participants in total, of which 16 will be Assyrian, 16 Vietnamese and 16 Mandaean.
The primary quantitative analysis will focus on feasibility outcomes using descriptive analysis. The number of participants screened, participant eligibility and recruitment rates will be presented. We will also present the characteristics of participants, number of withdrawals from the trial for each treatment arm and the numbers/percentages of dropouts who do not attend follow-up evaluation. Acceptance of the interventions (attendance, adherence and satisfaction) will be reported using descriptive statistics with independent samples t-tests used for between group comparisons. Exploratory analysis of the treatment effect will be conducted using intention-to-treat analyses, according to last data carried forward, per group allocation. Significance levels will be set at <0.05 with two-tailed tests. Effect size for the secondary clinical outcome measures will be explored using repeated measures analysis of variance (ANOVA) and effect size calculated using partial η2. Repeated measures ANOVA will be used with factors of intervention (usual care/culturally adapted intervention) and time (preintervention/postintervention). If outcome data are not normally distributed, then differences will be assessed using transformed data or appropriate non-parametric tests. We will report mean differences in outcomes between arms with 95% CIs. The size of the treatment effect will be used to determine whether it is worthwhile to conduct a full-scale RCT. All statistical analysis will be undertaken by the primary author using the Statistical Package for the Social Sciences (SPSS) Version 24, using an anonymised spreadsheet following data entry by an operator blinded to treatment allocation.
Ethics and dissemination
All participants will provide voluntary written informed consent. Prospective participants will be fully informed about what study participation involves and the potential benefits and risks, using an interpreter or bilingual physiotherapist where necessary. Ethics approval has been obtained from the SWSLHD HREC (HREC/16/LPOOL/194) and Western Sydney University Human Research Ethics Committee (RH11741). Any protocol amendments will be submitted for ethical approval and communicated to the trial registry. All investigators will have access to interim analyses. The results arising from this pilot RCT will be presented at scientific meetings and published in peer-reviewed journals. There is no intention to use professional writers and authorship will be based on the International Committee of Medical Journal Editors guidelines.
This paper describes the protocol for the cultural adaptation of physiotherapy assessment and treatment of chronic pain in three CALD communities (Assyrian, Mandaean and Vietnamese). The results of the pilot trial will enable clinicians and service providers to make informed decisions regarding the feasibility of adapting physiotherapy approaches to suit the beliefs and values of culturally diverse patients. As the first trial to evaluate a culturally adapted physiotherapy assessment and treatment approach for chronic pain, this study has been primarily designed to assess the feasibility and acceptability of delivering the novel approaches. Therefore, this study is not adequately powered to determine treatment effectiveness and further studies will be necessary to demonstrate the efficacy and generalisability of the findings to physiotherapy services beyond SWSLHD and the Vietnamese, Mandaean or Assyrian communities included.
Recruitment started in July 2016. At the time of protocol submission this study is recruiting participants. The pilot trial is expected to be completed (including follow-up testing) by June 2017.
Contributors BB, IV, SS and LC were involved in the conception, design, writing and editing of the study protocol. All authors approved the final protocol.
Competing interests None declared.
Ethics approval South West Sydney Local Health District Human Research Ethics Committee.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.